Mednet Logo
HomeQuestion

Would you ever consider foregoing surveillance CT scans for resected stage II or III colon cancer in favor of circulating ctDNA assays?

1 Answers
Mednet Member
Mednet Member
Medical Oncology

As someone who was introduced to CEA in colon surveillance when discovered simultaneously by Gold and LoGerfo in the early 1970s, I am excited by the rapid acceptance of ctDNA in evaluation and management of colon cancer. We know that ctDNA can be positive up to 9 months before a CT scan demonstrate...

Register or Sign In to see full answer

Would you ever consider foregoing surveillance CT scans for resected stage II or III colon cancer in favor of circulating ctDNA assays? | Mednet